- Home
- FRHC vs MDGL Comparison
FRHC vs MDGL Comparison
Compare FRHC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRHC
- MDGL
- Stock Information
- Founded
- FRHC N/A
- MDGL 2011
- Country
- FRHC United States
- MDGL United States
- Employees
- FRHC N/A
- MDGL N/A
- Industry
- FRHC Investment Bankers/Brokers/Service
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- FRHC Finance
- MDGL Health Care
- Exchange
- FRHC Nasdaq
- MDGL Nasdaq
- Market Cap
- FRHC 8.7B
- MDGL 9.6B
- IPO Year
- FRHC N/A
- MDGL N/A
- Fundamental
- Price
- FRHC $138.50
- MDGL $545.76
- Analyst Decision
- FRHC
- MDGL Strong Buy
- Analyst Count
- FRHC 0
- MDGL 13
- Target Price
- FRHC N/A
- MDGL $529.00
- AVG Volume (30 Days)
- FRHC 108.3K
- MDGL 414.2K
- Earning Date
- FRHC 11-07-2025
- MDGL 11-04-2025
- Dividend Yield
- FRHC N/A
- MDGL N/A
- EPS Growth
- FRHC N/A
- MDGL N/A
- EPS
- FRHC 0.08
- MDGL N/A
- Revenue
- FRHC $1,563,510,000.00
- MDGL $740,640,000.00
- Revenue This Year
- FRHC N/A
- MDGL $395.75
- Revenue Next Year
- FRHC N/A
- MDGL $65.73
- P/E Ratio
- FRHC $1,826.88
- MDGL N/A
- Revenue Growth
- FRHC 16.04
- MDGL 864.21
- 52 Week Low
- FRHC $111.85
- MDGL $265.00
- 52 Week High
- FRHC $194.01
- MDGL $544.25
- Technical
- Relative Strength Index (RSI)
- FRHC 32.53
- MDGL 72.49
- Support Level
- FRHC $134.00
- MDGL $505.00
- Resistance Level
- FRHC $143.36
- MDGL $544.25
- Average True Range (ATR)
- FRHC 6.07
- MDGL 30.49
- MACD
- FRHC -0.43
- MDGL 9.33
- Stochastic Oscillator
- FRHC 19.42
- MDGL 94.66
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.